Nu Skin Enterprises (NUS) Getting Somewhat Positive Media Coverage, Accern Reports

News stories about Nu Skin Enterprises (NYSE:NUS) have trended somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nu Skin Enterprises earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.373746329046 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

Several research firms have recently weighed in on NUS. Pivotal Research restated a “buy” rating and set a $90.00 price objective on shares of Nu Skin Enterprises in a research note on Friday, February 16th. ValuEngine upgraded shares of Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 2nd. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, December 20th. Stifel Nicolaus boosted their price objective on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the stock a “sell” rating in a research note on Friday, February 16th. Finally, Citigroup restated a “buy” rating and set a $81.00 price objective (up from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday, January 23rd. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $71.29.

Nu Skin Enterprises stock opened at $73.10 on Friday. The stock has a market cap of $3,958.89, a PE ratio of 22.63, a PEG ratio of 2.09 and a beta of 1.36. Nu Skin Enterprises has a fifty-two week low of $52.88 and a fifty-two week high of $75.82. The company has a current ratio of 1.74, a quick ratio of 1.17 and a debt-to-equity ratio of 0.44.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.01. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The company had revenue of $666.20 million for the quarter, compared to analyst estimates of $667.39 million. During the same period in the previous year, the business earned $0.79 EPS. Nu Skin Enterprises’s revenue for the quarter was up 25.4% compared to the same quarter last year. research analysts expect that Nu Skin Enterprises will post 3.56 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 14th. Investors of record on Monday, February 26th were paid a $0.365 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.46 dividend on an annualized basis and a yield of 2.00%. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.36. Nu Skin Enterprises’s dividend payout ratio is 45.20%.

In related news, General Counsel D Matthew Dorny sold 2,000 shares of the company’s stock in a transaction dated Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total value of $150,000.00. Following the transaction, the general counsel now owns 47,878 shares in the company, valued at approximately $3,590,850. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman Steven Lund sold 13,978 shares of the company’s stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $70.01, for a total transaction of $978,599.78. Following the completion of the transaction, the chairman now owns 4,769 shares in the company, valued at approximately $333,877.69. The disclosure for this sale can be found here. In the last quarter, insiders sold 141,843 shares of company stock worth $10,393,337. 5.20% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/08/nu-skin-enterprises-nus-getting-somewhat-positive-media-coverage-accern-reports.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply